PhD student at University of Bologna
Cardiovascular toxicities reported with Poly ADP Ribose Polymerase (PARP) inhibitors in the FDA Adverse Event Reporting System
Event: ESC Cardio-Oncology 2025
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Session: Innovations and new insights in cardio oncology
